This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Judge closes FCPA case against Teva Russia unit, imposes no new fine on top of prior $283 million fine

( July 13, 2017, 16:10 GMT | Official Statement) -- MLex Summary: US District Judge Kathleen Williams closed the criminal bribery case against Teva LLC, the Russian subsidiary of Teva Pharmaceuticals, after Teva LLC pleaded guilty last month. The judgement imposes no fine on top of the $283 million fine the Teva parent company agreed to pay in December when it settled a number of Foreign Corrupt Practices Act charges with a deferred prosecution agreement. Part of that DPA called for the Russian subsidiary to plead guilty to one count of a FCPA violation. The judgement allows the $283 million, which has been sitting in a US escrow account, to be released to the US Treasury.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections